YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Vitamin D as a Therapeutic Adjunct in the Stimulant Treatment of ADHD: a Proof-of-concept Tele-health Study of Stimulant-induced Improvement in Neurocognitive Functioning.

Phase 1

Terminated

Conditions: ADHD

Interventions: Other: Placebo
Drug: Calcitriol

First Posted Date: 2020-05-13

Last Posted Date: 2024-02-07

Lead Sponsor: Yale University

Target Recruit Count: 3

Registration Number: NCT04386811

Locations: 🇺🇸
CMHC, New Haven, Connecticut, United States

Preliminary Effectiveness of Remotely Monitored Blood Alcohol Concentration Device as Treatment Modality

Not Applicable

Completed

Conditions: Alcohol Use Disorder

Interventions: Device: Soberlink

First Posted Date: 2020-05-08

Last Posted Date: 2023-05-26

Lead Sponsor: Yale University

Target Recruit Count: 96

Registration Number: NCT04380116

Locations: 🇺🇸
Aware Recovery Care, North Haven, Connecticut, United States

Thymectomy With and Without Povidone-iodine Pleural Lavage in Stage IVA Thymic Malignancies

Phase 1

Withdrawn

Conditions: Stage IVA Thymoma

Interventions: Drug: Intraoperative providone-iodine lavage

First Posted Date: 2020-05-01

Last Posted Date: 2022-07-25

Lead Sponsor: Yale University

Registration Number: NCT04371458

Toward a Computationally-Informed, Personalized Treatment for Hallucinations

Early Phase 1

Recruiting

Conditions: Hallucinations, Auditory
Psychosis

Interventions: Drug: Rivastigmine Transdermal System
Drug: Scopolamine
Drug: Placebo Patch

First Posted Date: 2020-04-29

Last Posted Date: 2025-06-05

Lead Sponsor: Yale University

Target Recruit Count: 35

Registration Number: NCT04366518

Locations: 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States

Evaluation of the Clinical and Psychological Impact of Vitamin D Replacement in Adolescent Females at Risk for Polycystic Ovarian Syndrome (PCOS)

Not Applicable

Not yet recruiting

Conditions: Polycystic Ovarian Syndrome in Adolescent Females
Vitamin D Deficiency

Interventions: Drug: Vitamin D 4000IU daily
Drug: Placebo

First Posted Date: 2020-04-21

Last Posted Date: 2025-03-07

Lead Sponsor: Yale University

Target Recruit Count: 60

Registration Number: NCT04355572

Camostat Mesylate in COVID-19 Outpatients

Phase 2

Completed

Conditions: COVID-19

Interventions: Drug: Camostat Mesilate
Other: Placebo

First Posted Date: 2020-04-20

Last Posted Date: 2022-03-24

Lead Sponsor: Yale University

Target Recruit Count: 70

Registration Number: NCT04353284

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

An Augmented Reality Videogame for Alcohol Use Prevention and Harm Reduction in Teens

Not Applicable

Not yet recruiting

Conditions: Alcohol Prevention
Harm Reduction

First Posted Date: 2020-04-17

Last Posted Date: 2025-04-09

Lead Sponsor: Yale University

Target Recruit Count: 20

Registration Number: NCT04351958

Locations: 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States

Comparison of Intravascular Uptake and Pain Perception During Epidural Injection Using 22 Gauge vs 25 Gauge Needle

Not Applicable

Completed

Conditions: Needle Injury
Pain

Interventions: Device: 22-gauge needle
Device: 25-gauge needle

First Posted Date: 2020-04-17

Last Posted Date: 2020-07-20

Lead Sponsor: Yale University

Target Recruit Count: 162

Registration Number: NCT04350307

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Efficacy of Laparoscopic-assisted Transversus Abdominus Plane (TAP) Block Compared to Ultrasound-guided TAP Block in Minimally Invasive Gynecologic Surgeries: A Prospective, Randomized Control Trial.

Phase 2

Completed

Conditions: the Efficacy of Analgesia of Laparoscopic TAP Block in Minimally Invasive Gynecology Surgeries

Interventions: Drug: TAP block with liposomal bupivacaine and bupivacaine

First Posted Date: 2020-04-14

Last Posted Date: 2023-11-18

Lead Sponsor: Yale University

Target Recruit Count: 80

Registration Number: NCT04345341

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

The Role of Resistant Starch in COVID-19 Infection

Phase 2

Terminated

Conditions: COVID-19

Interventions: Drug: Dietary Supplement containing resistant starch
Dietary Supplement: Placebo Starch

First Posted Date: 2020-04-13

Last Posted Date: 2022-10-05

Lead Sponsor: Yale University

Target Recruit Count: 226

Registration Number: NCT04342689

Locations: 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
🇺🇸
Yale University, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy